Association of the HTR6 polymorphism C267T with late-onset Alzheimer's disease in Chinese

被引:17
作者
Kan, R
Wang, BB
Zhang, CF
Yang, Z
Ji, S
Lu, ZP
Zheng, CG
Jin, F [1 ]
Wang, L
机构
[1] Chinese Acad Sci, Ctr Human & Anim Genet, Inst Genet & Dev Biol, Beijing 100101, Peoples R China
[2] Inner Mongolia Univ, Fac Life Sci, Hohhot 010021, Peoples R China
[3] Chinese Acad Sci, Grad Sch, Beijing 100101, Peoples R China
[4] Beijing Hosp, Minist Hlth, Inst Geriatr, Beijing 100730, Peoples R China
[5] Jiangbin Hosp, Guanhxi 530021, Peoples R China
关键词
late-onset Alzheimer's disease; HTR6; 5-HT6; receptor; APOE; polymorphism; cognitive process; Chinese;
D O I
10.1016/j.neulet.2004.09.007
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Serotonergic neurotransmitter system has been implicated in the pathogenesis of Alzheimer's disease (AD). 5-Hydroxytryptamine (5-HT)(6) receptor is mainly expressed in the brain areas involved in cognitive processes. And 5-HT6 receptor gene (HTR6) variants may be a genetic risk factor for late-onset Alzheimer's disease (LOAD). To assess whether HTR6 increases the risk for LOAD, we carried out an association study between the HTR6 polymorphism C267T and sporadic LOAD in Mainland Chinese. An association of C/T genotype with LOAD (OR = 2.10. P = 0.014) was observed. And no statistical difference was found between cases and controls after stratification for APOE epsilon4 status. These data suggest that the HTR6 polymorphism C267T possibly involved in the susceptibility to LOAD as an APOE epsilon4-allele independent risk factor of LOAD. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:27 / 29
页数:3
相关论文
共 20 条
  • [1] 5-hydroxytryptamine 6 receptor (5-HT6) receptor and apolipoprotein E (ApoE) polymorphisms in patients with Alzheimer's disease in the Basque Country
    Alvarez-Alvareza, M
    Galdos, L
    Fernández-Martínez, M
    Gómez-Busto, F
    García-Centeno, V
    Arias-Arias, C
    Sánchez-Salazar, C
    Rodríguez-Martínez, AB
    Zarranz, JJ
    de Pancorbo, MM
    [J]. NEUROSCIENCE LETTERS, 2003, 339 (01) : 85 - 87
  • [2] ApoE-4 and age at onset of Alzheimer's disease: The NIMH genetics initiative
    Blacker, D
    Haines, JL
    Rodes, L
    Terwedow, H
    Go, RCP
    Harrell, LE
    Perry, RT
    Bassett, SS
    Chase, G
    Meyers, D
    Albert, MS
    Tanzi, R
    [J]. NEUROLOGY, 1997, 48 (01) : 139 - 147
  • [3] BOURSON A, 1995, J PHARMACOL EXP THER, V274, P173
  • [4] Differential involvement of 5-HT1B/1D and 5-HT6 receptors in cognitive and non-cognitive symptoms in Alzheimer's disease
    Garcia-Alloza, M
    Hirst, WD
    Chen, CPLH
    Lasheras, B
    Francis, PT
    Ramírez, MJ
    [J]. NEUROPSYCHOPHARMACOLOGY, 2004, 29 (02) : 410 - 416
  • [5] Hu Xue-Fang, 2002, Acta Genetica Sinica, V29, P757
  • [6] Kohen R, 1996, J NEUROCHEM, V66, P47
  • [7] Risperidone response and 5-HT6 receptor gene variance:: genetic association analysis with adjustment for nongenetic confounders
    Lane, HY
    Lin, CC
    Huang, CH
    Chang, YC
    Hsu, SK
    Chang, WH
    [J]. SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 63 - 70
  • [8] MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
  • [9] Meltzer CC, 1998, NEUROPSYCHOPHARMACOL, V18, P407
  • [10] Meneses A, 1998, REV NEUROSCIENCE, V9, P275